(Press-News.org) BERLIN, Germany – Stealth BioTherapeutics, a front-runner in the world of mitochondrial medicine, is set to unveil its latest breakthroughs at the much-anticipated Targeting Mitochondria 2023 conference in Berlin this October.
Dr. David A. Brown, Vice President of Mitochondrial Research at Stealth BioTherapeutics, is slated to give an enlightening talk titled, “Translational insights from targeting mitochondria in rare diseases.” His presentation promises to provide insights into Stealth’s progress in clinical programs, with updates on their advancements in addressing rare mitochondrial diseases across several Phase 2/3 clinical trials. Furthermore, he will elaborate on the emerging strategies to counteract mitochondrial dysfunction in various pathologies.
About Stealth BioTherapeutics:
Stealth BioTherapeutics is a clinical-stage biotechnology firm dedicated to the discovery, development, and commercialization of groundbreaking therapies targeting diseases caused by mitochondrial dysfunction. Dysfunctional mitochondria play a pivotal role in a myriad of rare genetic diseases as well as numerous prevalent age-related conditions. These typically affect organ systems with high energy needs, such as the eye, the neuromuscular system, the heart, and the brain.
About World Mitochondria Society:
The World Mitochondria Society is an international non-profit organization dedicated to promoting research and education about mitochondria in health and disease. It aims to bridge the gap between scientists and healthcare professionals globally, disseminating knowledge and fostering collaborations to advance the understanding of mitochondrial function and dysfunction.
END
Stealth BioTherapeutics will spotlight latest advancements in mitochondrial medicine at Targeting Mitochondria 2023, Berlin
2023-08-22
ELSE PRESS RELEASES FROM THIS DATE:
MIT engineers use kirigami to make ultrastrong, lightweight structures
2023-08-22
Cellular solids are materials composed of many cells that have been packed together, such as a honeycomb. The shape of those cells largely determines the material’s mechanical properties, including its stiffness or strength. Bones, for instance, are filled with a natural material that enables them to be lightweight, but stiff and strong.
Inspired by bones and other cellular solids found in nature, humans have used the same concept ...
$1.7 million research project to examine how public schools identify learning disabilities
2023-08-22
A University of Houston researcher is launching a new study to examine how elementary schools across Texas and Florida identify specific learning disabilities in students, with the goal of improving processes so children with significant academic difficulties can succeed.
Jeremy Miciak, research associate professor of psychology at the University of Houston’s Texas Institute for Measurement, Evaluation, and Statistics, was awarded a $1.7 million grant from the National Center for Special Education Research at the Institute of Education Sciences, the research arm ...
Catheter ablation in very old patients with nonvalvular atrial fibrillation
2023-08-22
“To the best of our knowledge, this is the first study to have demonstrated the preventive effect of AF ablation on long-term AF-related cardiovascular events in very old patients with NVAF.”
BUFFALO, NY- August 22, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 15, entitled, “Cardiovascular events and death after catheter ablation in very old patients with nonvalvular ...
Researchers decode new antibiotic
2023-08-22
More and more bacterial pathogens are developing resistance. There is an increasing risk that common drugs will no longer be effective against infectious diseases. That is why scientists around the world are searching for new effective substances. Researchers from the University of Bonn, the German Center for Infection Research (DZIF), Utrecht University (Netherlands), Northeastern University in Boston (USA) and the company NovoBiotic Pharmaceuticals in Cambridge (USA) now have discovered and deciphered the mode of action of a new antibiotic. Clovibactin is derived from ...
Wistar researchers discover potential target for gastric cancers associated with Epstein-Barr virus
2023-08-22
PHILADELPHIA—(August 22, 2023)—Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio. In the paper, Wistar’s Tempera lab investigates the epigenetic characteristics of gastric cancer associated with the Epstein-Barr Virus: EBVaGC. In evaluating EBVaGC’s epigenetics — the series of biological signals associated with the genome that determines whether a given gene is expressed — the Tempera lab ...
Advances in quantum emitters mark progress toward a quantum internet
2023-08-22
– By Alison Hatt
The prospect of a quantum internet, connecting quantum computers and capable of highly secure data transmission, is enticing, but making it poses a formidable challenge. Transporting quantum information requires working with individual photons rather than the light sources used in conventional fiber optic networks. To produce and manipulate individual photons, scientists are turning to quantum light emitters, also known as color centers. These atomic-scale defects in semiconductor materials can emit single photons of fixed wavelength or color and allow photons to interact with electron spin properties in controlled ways.
A team ...
Scientists create 3D models of freshwater mussels to help save them from extinction
2023-08-22
Scientists and imaging specialists have teamed up to help save one of the world’s most endangered groups of animals: freshwater mussels. With funding provided by the U.S. Fish and Wildlife Service’s National Conservation Training Center, imaging experts will create 3D shell models based on specimens from the Florida Museum of Natural History and the Smithsonian Institution’s National Museum of Natural History.
Once complete, the models will be available online for free to educate the public about these amazing yet little-known creatures that ...
How bacteria surf cargo through the cell
2023-08-22
Bacteria live in nearly every habitat on earth including within soil, water, acidic hot springs and even within our own guts.
Many are involved in fundamental processes like fermentation, decomposition and nitrogen fixation. But scientists don’t understand a fundamental process within bacteria cells: how they organize themselves before division.
Driving vs. surfing
When cells divide the cell splits into two “daughter cells” with the same genetic material as the original cell.
During this process, the DNA and other cellular components replicate, and then this “cargo” ...
JMIR Nursing Call for Papers Theme Issue on Artificial Intelligence (AI) in Nursing
2023-08-22
JMIR Nursing Editor-in-Chief: Elizabeth Borycki RN, PhD, FIAHIS, FACMI, FCAHS and theme editor Kenrick Dwain Cato, PhD, RN, CPHIMS, FAAN welcome submissions to a special theme issue examining "Artificial Intelligence (AI) in Nursing."
AI is revolutionizing health care. Nurse informaticist developers, researchers, practitioners, clinicians, educators, and innovators have designed, developed, implemented, and used AI to support patients, their families, nurses and health care activities.
AI has been used to support ...
New study sheds light on the molecular mechanisms underlying SLC29A3 disorders
2023-08-22
In humans, the SLC29A3 gene regulates the function of lysosomes to control waste recycling in cells such as macrophages (that engulf and destroy foreign bodies). This gene encodes for the lysosomal protein that transport nucleosides — degradation products of RNA and DNA — from lysosomes to the cytoplasm. Loss-of-function mutations in the SLC29A3 gene lead to aberrant nucleoside storage, resulting in a spectrum of conditions called SLC29A3 disorders. These disorders can manifest in the form of pigmented skin patches, enlargement of the liver/spleen, hearing loss, or type 1 diabetes. A key manifestation of this group of disorders is histiocytosis, ...